Apollo Endosurgery Inc APEN:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 12:30 PM EST
5.00quote price arrow up+0.39 (+8.34%)
Volume
205,012
52 week range
1.24 - 6.12

...

Loading . . .

KEY STATS

  • Open4.62
  • Day High5.15
  • Day Low4.62
  • Prev Close4.61
  • 52 Week High6.12
  • 52 Week High Date02/09/21
  • 52 Week Low1.24
  • 52 Week Low Date03/19/20
  • Market Cap128.90M
  • Shares Out25.78M
  • 10 Day Average Volume0.13M
  • Dividend-
  • Dividend Yield-
  • Beta2.10
  • 1 Year % Change85.66

RATIOS/PROFITABILITY

  • EPS (TTM)-1.24
  • P/E (TTM)-4.04
  • Fwd P/E (NTM)-5.41
  • EBITDA (MRQ)-15.687M
  • ROE (MRQ)-258.27%
  • Revenue (MRQ)41.18M
  • Gross Margin (MRQ)50.72%
  • Net Margin (MRQ)-63.88%
  • Debt To Equity (MRQ)548.67%

EVENTS

  • Earnings Date05/04/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Apollo Endosurgery Inc News

There is no recent news for this security.

Latest APEN News From Our Partners

QUOTE FINDER

Profile

MORE
Apollo Endosurgery, Inc., formerly Lpath, Inc., is a medical device company. The Company is focused on less invasive therapies for the treatment of obesity, as well as other gastrointestinal disorders. The Company's device-based therapies are an alternative to invasive surgical procedures. The Company offers products in over 80 countries. The Company's products include ORBERA, LAP-BAND and OverStitch. The Company's product, ORBERA, is a gastric balloon. The ORBERA...
Todd Newton CPA
Chief Executive Officer
Stefanie Cavanaugh CPA
Chief Financial Officer
John Molesphini
Executive Vice President
Bret Schwartzhoff
Vice President
Address
1120 South Capital Of Tx Hwy
Building 1 Suite 300
West Lake Hills, TX
78746-6464
United States